Skip to content
Peptigraph home

Oxytocin

Neuropeptide hormone. Oxytocin is FDA approved (prescription only); research-chemical versions are not the approved drug.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated Strongest evidence: Human RCT evidence, 4 of 4
StatusFDA approved (prescription only)Not on the WADA Prohibited ListFull legal history

Key facts

Class
Neuropeptide hormone
Also called
No common aliases
Vial sizes sold
2 mg, 10 mg
Community-reported sizes
Half-life
plasma half-life about 1 to 6 minutes
intravenous/intramuscular (Pitocin), in people · FDA label (Pitocin)
FDA status
Approved (prescription only)
Approved
WADA
Not listed
2026 Prohibited List
Everything on Oxytocin

Oxytocin guides

Evidence at a glance

Human and animal counts are PubMed records from our evidence ledger (search counts, not studies we reviewed). The grade is the strongest design among the studies we summarised for that goal: a human randomized trial outweighs any number of animal studies.

Oxytocin: studies by condition
ConditionHuman studiesAnimal studiesStudies we summarisedEvidence grade
Weight lossNot in our ledgerNot in our ledger3Human RCT evidence, 4 of 4Journal of the American Medical Directors Association 2021, PMID 34029521

Grades follow our evidence scale. Summarised studies come from our evidence file, each quote checked against the abstract or label.

Two unrelated bodies of evidence

The approved product, Pitocin, is indicated for initiating or improving uterine contractions where that is considered suitable for fetal or maternal reasons.[4]

The label gives a plasma half-life of about 1 to 6 minutes, shorter in late pregnancy and during lactation.[4]

In obstetric use, a meta-analysis found that prophylactic doses of 4 to 10 IU meant 6 to 7 fewer individuals per 1000 with blood loss of 1000 mL or more.[10]

Intranasal research: the autism result is the key negative

In a large randomized trial of intranasal oxytocin in children and adolescents with autism, the primary outcome changed by -3.7 on oxytocin and -3.5 on placebo, a difference with P = 0.61.[11]

A small pilot trial in older adults with sarcopenic obesity reported a 2.25 kg lean-mass gain on intranasal oxytocin versus placebo.[9]

Intranasal oxytocin at the higher dose raised plasma oxytocin levels to 48.0 pg/ml, 30-60 minutes after the spray.[12]

Regulatory path

Drugs@FDA lists oxytocin injection from several sponsors; the record quoted is a 10 USP units/mL injectable with an original approval date of 20130213.[2]

WADA's S0 catch-all applies only to substances with no government approval, so approved oxytocin is outside it.[1]

Common questions

Is Oxytocin FDA approved?

Oxytocin is FDA approved (prescription only). Products sold as research chemicals are not the approved drug and are not checked by the FDA.

How much water goes in a 10 mg vial?

That choice only changes the concentration. With 2 mL, the vial is 5 mg/mL. The calculator converts any amount to syringe units. It does the math only and does not suggest a dose.

What is oxytocin?

A hormone whose approved use, per the Pitocin label, is initiating or improving uterine contractions. Nasal-spray research is a separate literature.[4]

Does intranasal oxytocin help autism?

In the large randomized trial cited here it did not beat placebo on the primary outcome.[11]

Is oxytocin a controlled substance?

The Pitocin label marks it prescription-only; the label text this site cached lists no DEA schedule, and the label does not itself say whether oxytocin is controlled.[4]

Is oxytocin banned in sport?

This site's check of WADA's current list finds oxytocin not named; the list's catch-all clause covers only substances without government approval for human therapeutic use, and oxytocin has approved medicines.[1]

Is oxytocin still prescribed?

Yes, as an approved injection: the current Pitocin label lists initiating or improving uterine contractions, where suitable for fetal or maternal reasons, as a use that aims at vaginal delivery.[4]

Sources

  1. 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  2. 2United States: Approved by FDA: oxytocin injection NDAs/ANDAs (Pitocin, Par; generics from Fresenius Kabi, Hikma, Sagent) for initiation or improvement of uterine contractions in obstetric use (label quote).U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  3. 3Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With Obesity.The Journal of clinical endocrinology and metabolism · 2025PMID 40314146Accessed 2 Oct 2026
  4. 4Pitocin ® (Oxytocin Injection, USP) SyntheticFDA label (Pitocin), DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
  5. 5PubMed search: (oxytocin[ti]) AND intranasal[tiab] AND randomized controlled trial[pt] AND humans[mh] (444 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: (oxytocin[tiab]) AND (obesity[tiab] OR "weight loss"[tiab]) AND humans[mh] AND (randomized controlled trial[pt] OR clinical trial[pt]) (36 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7PubMed search: oxytocin[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) AND humans[mh] (135 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  8. 8PubMed search: (oxytocin[ti] AND postpartum hemorrhage[ti]) AND (meta-analysis[pt] OR randomized controlled trial[pt]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9Intranasal Oxytocin Improves Lean Muscle Mass and Lowers LDL Cholesterol in Older Adults with Sarcopenic Obesity: A Pilot Randomized Controlled Trial.Journal of the American Medical Directors Association · 2021PMID 34029521Accessed 2 Oct 2026
  10. 10Prophylactic oxytocin dose following vaginal birth to prevent postpartum hemorrhage: a systematic review and dose-response meta-analysis.American journal of obstetrics and gynecology · 2026PMID 41005452Accessed 2 Oct 2026
  11. 11Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.The New England journal of medicine · 2021PMID 34644471Accessed 2 Oct 2026
  12. 12Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans.Psychoneuroendocrinology · 2014PMID 24882155Accessed 2 Oct 2026

Found an error? Report a correction.